Search

Population dose-Hgb modelling of Jesduvroq (daprodustat) across five phase 3 studies in chronic kidney disease patients with anemia.

Therapeutic area :

Noort van M., Berg van den P., Post T.M., Beerahee M., Mahar K.M., Yang S. Population dose-Hgb modelling of Jesduvroq (daprodustat) across five phase 3 studies in chronic kidney disease patients with anemia. PAGE 2023 [Link to publication]

Our expertise

Methods Safety pharmacology Anti-infectives and immunology Endocrinology/Sexual health Biologicals Cardiovascular Paediatrics Anesthesiology CNS Blood disorders Diabetes Oncology Gastrointestinal Diseases General modelling Peripheral Nervous System Lung Diseases Pain